The cyclin‐dependent kinase 4 (CDK4) nucleotide substitution confers protection to CDK4 from inhibition by the INK family of cell cycle inhibitors, thereby ameliorating glucose intolerance in IRS2‐deficient mice. The gene discussed is CDK4; the disease is Glucose intolerance.